tiprankstipranks
ERYTECH PHARMA (GB:0QSS)
LSE:0QSS
Holding GB:0QSS?
Track your performance easily

ERYTECH PHARMA (0QSS) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
ERYTECH PHARMA’s (0QSS) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting ERYTECH PHARMA is a Sell.
ERYTECH PHARMA’s (0QSS) 20-Day exponential moving average is 1.69, while ERYTECH PHARMA’s (0QSS) share price is €1.74, making it a Buy.
ERYTECH PHARMA’s (0QSS) 50-Day exponential moving average is 1.73, while ERYTECH PHARMA’s (0QSS) share price is €1.74, making it a Buy.

ERYTECH PHARMA (0QSS) Pivot Points

Dec 12, 2024, 01:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.72
1.72
1.72
1.72
1.72
1.72
1.72
Fibonacci
1.72
1.72
1.72
1.72
1.72
1.72
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ERYTECH PHARMA (0QSS) Moving Averages

Dec 12, 2024, 01:43 AM
Period
Simple
Exponential
MA5
1.68Buy
1.70Buy
MA10
1.65Buy
1.68Buy
MA20
1.67Buy
1.69Buy
MA50
1.74Sell
1.73Buy
MA100
1.79Sell
1.87Sell
MA200
2.17Sell
2.31Sell
ERYTECH PHARMA’s (0QSS) 10-Day exponential moving average is 1.68, while ERYTECH PHARMA’s (0QSS) share price is €1.74, making it a Buy.
ERYTECH PHARMA’s (0QSS) 100-Day exponential moving average is 1.87, while ERYTECH PHARMA’s (0QSS) share price is €1.74, making it a Sell.
ERYTECH PHARMA’s (0QSS) stock price is €1.74 and ERYTECH PHARMA’s (0QSS) 50-day simple moving average is 1.74, creating a Sell signal.
ERYTECH PHARMA’s (0QSS) stock price is €1.74 and ERYTECH PHARMA’s (0QSS) 100-day simple moving average is 1.79, creating a Sell signal.
ERYTECH PHARMA’s (0QSS) stock price is €1.74 and ERYTECH PHARMA’s (0QSS) 200-day simple moving average is 2.17, creating a Sell signal.

ERYTECH PHARMA (0QSS) Technical Indicators

Dec 12, 2024, 01:43 AM
Name
Value
Implied Action
RSI (14)
54.59
Neutral
STOCH (9,6)
83.33
Sell
STOCHRSI (14)
85.66
Sell
MACD (12,26)
-0.02
Sell
ADX (14)
22.87
Neutral
Williams %R
-10.75
Sell
CCI (14)
49.33
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
68.00
Neutral
ROC
9.43
Buy
ERYTECH PHARMA’s (0QSS) Relative Strength Index (RSI) is 54.59, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Trend Strength Indicator (ADX) is 22.87, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Commodity Channel Index (CCI) is 49.33, creating a Neutral signal.
ERYTECH PHARMA’s (0QSS) Price Rate of Change (ROC) is 9.43, creating a Buy signal.

FAQ

Is 0QSS a Buy, Hold, or Sell?
Based on 0QSS’s technical indicators, 0QSS is a Hold.
    What is 0QSS’s RSI (14)?
    0QSS’s RSI (14) is 54.59, which suggests 0QSS is a Neutral.
      What is 0QSS’s MACD?
      0QSS’s MACD is -0.02, which suggests 0QSS is a Sell.
        What is 0QSS’s 5-day moving average?
        0QSS’s 5-day moving average is 1.68, which suggests 0QSS is a Buy.
          What is 0QSS’s 20-day moving average?
          0QSS 20-day moving average is 1.67, which suggests 0QSS is a Buy.
            What is 0QSS’s 50-day moving average?
            0QSS’s 50-day moving average is 1.74, which suggests 0QSS is a Sell.
              What is 0QSS’s 200-day moving average?
              0QSS’s 200-day moving average is 2.17, which suggests 0QSS is a Sell.
                What is 0QSS’s Williams % R (14)?
                0QSS’s Williams % R (14) is -10.75, which suggests 0QSS is a Sell.
                  What is 0QSS’s CCI (14)?
                  0QSS’s CCI (14) is 49.33, which suggests 0QSS is a Neutral.
                    What is the share price of ERYTECH PHARMA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis